Edition:
United States

Chabiotech Co Ltd (085660.KQ)

085660.KQ on KOSDAQ - Korea Secs Dealers Association Quotation

12,800.00KRW
28 Apr 2017
Change (% chg)

₩0.00 (+0.00%)
Prev Close
₩12,800.00
Open
₩12,800.00
Day's High
₩12,850.00
Day's Low
₩12,700.00
Volume
185,226
Avg. Vol
232,827
52-wk High
₩18,150.00
52-wk Low
₩11,200.00

Latest Key Developments (Source: Significant Developments)

Chabiotech unit CHA Healthcare to buy 8.8 pct stake in SMG for 12.07 bln won
Sunday, 19 Feb 2017 10:29pm EST 

Chabiotech Co Ltd <085660.KQ> : Says its unit CHA Healthcare Co., Ltd will buy 30 million shares of SMG(Singapore Medical Group Limited) for 12.07 billion won .Says its unit CHA Healthcare Co., Ltd will hold 8.8 percent stake(30 million shares) in SMG after the transaction.  Full Article

Chabiotech completes issuance of fifth convertible bonds
Thursday, 21 Apr 2016 04:37am EDT 

Chabiotech Co.,Ltd:Completes the issuance of its fifth convertible bonds as of April 21.Proceeds of 20,000 mln won from the offering.  Full Article

Chabiotech completes issuance of fourth convertible bonds
Thursday, 21 Apr 2016 04:35am EDT 

Chabiotech Co.,Ltd:Completes the issuance of its fourth convertible bonds as of April 21.Proceeds of 24,000 mln won from the offering.  Full Article

Chabiotech to issue fifth convertible bonds
Tuesday, 19 Apr 2016 04:43am EDT 

Chabiotech Co.,Ltd:To issue the fifth unregistered/unsecured private convertible bonds, raising 20,000 mln won in proceeds for operations.Says maturity date of April 21, 2021, yield to maturity of 2.0 pct and annual coupon of 0 pct, lump-sum redemption of principal on maturity date for the bonds.Says a 100 pct conversion rate of bonds to common shares at 14,345 won per share, and a conversion period from April 21, 2017 to April 20, 2021.  Full Article

Chabiotech to issue fourth convertible bonds
Tuesday, 19 Apr 2016 04:43am EDT 

Chabiotech Co.,Ltd:To issue the fourth unregistered/unsecured private convertible bonds, raising 24,000 mln won in proceeds for operations.Says maturity date of April 21, 2021, yield to maturity of 2.0 pct and annual coupon of 0 pct, lump-sum redemption of principal on maturity date for the bonds.Says a 100 pct conversion rate of bonds to common shares at 14,345 won per share, and a conversion period from April 21, 2017 to April 20, 2020.  Full Article

Chabiotech receives approval for 1/2a clinic trial plan for alzheimer's disease
Wednesday, 11 Nov 2015 07:50pm EST 

Chabiotech Co.,Ltd:Receives approval from Ministry of Food and Drug safety, for a 1/2a clinic trial for alzheimer's disease (CB-AC-02).The clinic trail is for testing security and potential therapeutic effect of CB-AC-02 for alzheimer's disease.  Full Article

More From Around the Web

BRIEF-Chabiotech unit CHA Healthcare to buy 8.8 pct stake in SMG for 12.07 bln won

* Says its unit CHA Healthcare Co., Ltd will buy 30 million shares of SMG(Singapore Medical Group Limited) for 12.07 billion won